Commercialization Committee


The Commercialization Committee strives to:

  • Be the global communication hub between therapeutic societies, regulatory policy makers, institutional stem cell centres and industry for the advancement of clinical investigation in cell therapy and regenerative medicine.

Projects and Objectives

  • Drive industry/academic partnerships.
  • Identify and develop reimbursement roadmaps and partner to influence coding and pricing decisions.
  • Assist in developing partnerships and liaisons with appropriate clinical societies and/or sister societies.
  • The inaugural Commercialization Signature Series hosted on September 29, 2016.



Committee Chair


Miguel Forte, MD, PhD
mC4Tx, Bone Therapeutics
Brussels, Belgium


Committee Members



Julie Allickson, PhD, MSc, MT(ASCP)
Wake Forest Institute of Regenerative Medicine
Winston-Salem, NC, United States

Tim Allsopp, PhD
Pfizer Regenerative Medicine
Cambridge, United Kingdom

Dolores Baksh
GE Healthcare
Walkersville, MA, United States

Gerhard Bauer, PhD
UC Davis
Sacramento, CA, United States

Lynn Csontos
STEMCELL Technologies
Vancouver, BC, Canada

Dawn Driscoll, PhD, MBA
DCi Biotech
Perth, Australia

Simon Ellison, MBA
Fisher BioServices
London, United Kingdom

Ronald Fedechko
Cambridge, United Kingdom

John Fink, MBA
Brooks Life Science Systems
Chelmsford, MA, United States

Ian Gaudet, PhD
PCT Caladrius
Mountainview, CA, United States

Dina Isyemina, MSc
Terumo BCT
Lakewood, CO, United States

Nancy Johansen
Miltenyi Biotec
Woburn, MA, United States

Ohad Karnieli, PhD, MBA
Karnieli Inc.
Haifa, Israel

Eric Law
Celgene Cellular Therapeutics
Warren, MI, United States

Bruce Levine, PhD
University of Pennsylvania
Philadelphia, PA, United States

Aby Mathew, PhD
BioLiofe Solutions
Bothell, WA, United States

Robert Mays, PhD
Cleveland, OH, United States

Michael Mendicino, PhD
Hybrid Concepts International, LLC
Grand Island, NY, United States

Bill Milligan, BSc
Steminent Biotherapeutics
Vancouver, BC, Canada

Julie Murrell, PhD
EMD Millipore
Bedford, MA, United States

Brian Newsom, MSc
Thermo Fisher Scientific
Knoxville, TN, United States

Jessie Ni
Irvine Scientific
California, United States

Nathan Smith
Cell Therapies Pty Ltd
East Melbourne, VIC, Australia

David Williams, PhD
Loughborough University
Loughborough, United Kingdom

Claudia Zylberberg, PhD
Akron Biotech
Boca Raton, FL, United States

Ohad Karnieli, PhD, MBA
Pluristem Therapeutics
Haifa, Israel
Nathan Smith
Cell Therapies Pty Ltd
East Melbourne, VIC, AUS
Nathan Smith
Cell Therapies Pty Ltd
East Melbourne, VIC, AUS

© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.